LPA and infectious disease: The anti-LPA antibody, 504B3, binds other lipids beyond LPA. The use of antibody-based therapies has produced multiple therapeutic successes, ranging from cancer to autoimmune and infectious diseases [30–33], with the majority targeting protein epitopes.